These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8301856)

  • 1. [Natural history and URSO dissolution therapy of gallbladder stones in the elderly].
    Kumai T; Katoh N; Nakayama Y; Yamamoto T; Hayakawa T; Hoshino M; Miyaji M; Takeuchi T
    Nihon Ronen Igakkai Zasshi; 1993 Oct; 30(10):849-56. PubMed ID: 8301856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone.
    Podda M; Zuin M; Battezzati PM; Ghezzi C; de Fazio C; Dioguardi ML
    Gastroenterology; 1989 Jan; 96(1):222-9. PubMed ID: 2642440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Menthol in the adjuvant treatment of gallbladder stones fragmented by ESWL as an option for reducing doses of urso- and chenodeoxycholic acid].
    Ahrens O; Johanns W; Kölling U; Janssen J; Greiner L
    Med Klin (Munich); 2004 Jun; 99(6):279-84. PubMed ID: 15221054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, ultrasonographic, and roentgenographic study in 134 asymptomatic gallstone carriers. Is oral ursodeoxycholic acid treatment worthwhile?
    Lirussi F; Passera D; Iemmolo RM; Nassuato G; Okolicsanyi L
    Scand J Gastroenterol; 1993 Mar; 28(3):267-73. PubMed ID: 8446852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal shock wave lithotripsy of gallstones with oral dissolution. Results in course of ten years in Czech Republic in correlation to indication criteria.
    Benes J; Chmel J; Blazek O; Marecek Z
    Sb Lek; 2001; 102(1):17-22. PubMed ID: 11830914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term ursodeoxycholate administration on expression levels of secretory low-molecular-weight phospholipases A2 and mucin genes in gallbladders and biliary composition in patients with multiple cholesterol stones.
    Kano M; Shoda J; Irimura T; Ueda T; Iwasaki R; Urasaki T; Kawauchi Y; Asano T; Matsuzaki Y; Tanaka N
    Hepatology; 1998 Aug; 28(2):302-13. PubMed ID: 9695991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholelithiasis and acromegaly: therapeutic strategies.
    Montini M; Gianola D; Pagani MD; Pedroncelli A; Caldara R; Gherardi F; Bonelli M; Lancranjan I; Pagani G
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):401-6. PubMed ID: 8187305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oral dissolvents and extracorporeal lithotripsy: respective role and modalities of application].
    Erlinger S
    Rev Prat; 1992 Jun; 42(12):1487-9. PubMed ID: 1411171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral dissolution therapy for cholelithiasis: mix and match.
    Phillips RS; Barkin JS
    Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis.
    Tomida S; Abei M; Yamaguchi T; Matsuzaki Y; Shoda J; Tanaka N; Osuga T
    Hepatology; 1999 Jul; 30(1):6-13. PubMed ID: 10385632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol gallstone disease: the current status of nonsurgical therapy.
    Bilhartz LE
    Am J Med Sci; 1988 Jul; 296(1):45-56. PubMed ID: 3044106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsurgical management of gallstones.
    Sauerbruch T; Neubrand M
    Prog Liver Dis; 1992; 10():193-218. PubMed ID: 1296230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oral dissolving treatment of gallbladder calculi: focus in 1989].
    Erlinger S
    Ann Chir; 1989; 43(6):417-9. PubMed ID: 2817740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallstone recurrence after successful dissolution therapy.
    Tudyka J; Wechsler JG; Kratzer W; Maier C; Mason R; Kuhn K; Adler G
    Dig Dis Sci; 1996 Feb; 41(2):235-41. PubMed ID: 8601364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The piezoelectric lithotripsy of gallstones. The acute- and long-term results].
    Benninger J; Schneider HT; Blaufuss M; Rabenstein T; Flügel H; Hahn EG; Ell C
    Dtsch Med Wochenschr; 1992 Sep; 117(36):1350-4. PubMed ID: 1516528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical dissolution of gallstones by oral bile acid therapy.
    Hofmann AF
    Am J Surg; 1989 Sep; 158(3):198-204. PubMed ID: 2672842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic versus silent gallstones. Radiographic features and eligibility for nonsurgical treatment.
    Ros E; Valderrama R; Bru C; Bianchi L; Terés J
    Dig Dis Sci; 1994 Aug; 39(8):1697-703. PubMed ID: 8050320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of ursodeoxycholic acid to dissolve radiolucent gallstones in patients with cystic fibrosis.
    Colombo C; Bertolini E; Assaisso ML; Bettinardi N; Giunta A; Podda M
    Acta Paediatr; 1993; 82(6-7):562-5. PubMed ID: 8338990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal shock wave lithotripsy of gallstones: early experience in an Israeli population.
    Moshkowitz M; Erlich N; Halpern Z; Gilat T
    Isr J Med Sci; 1993 Nov; 29(11):677-9. PubMed ID: 8270393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intraduodenal administration of ursodeoxycholic acid on interdigestive interaction between gallbladder motility, pancreatic secretion and endocrine activity.
    Neubrand MW; Dominguez-Munoz JE; Reichel C; Kampmann S; Eschmann K; von Falkenhausen M; Bregulla M; Malfertheiner P; Sauerbruch T
    Digestion; 2004; 69(3):149-57. PubMed ID: 15114045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.